Literature DB >> 11978926

The pulmonary physician in critical care. 5: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology.

K Atabai1, M A Matthay.   

Abstract

An understanding of the epidemiology of ALI/ARDS and the effects of treatment have been hampered by the lack of a uniform definition of the syndrome. Various definitions have been proposed, and these are reviewed with particular attention to how changes in definition have affected our understanding of the natural history and treatment options for the condition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978926      PMCID: PMC1746331          DOI: 10.1136/thorax.57.5.452

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  45 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Agreement between alternative classifications of acute respiratory distress syndrome.

Authors:  M O Meade; G H Guyatt; R J Cook; R Groll; J R Kachura; M Wigg; D J Cook; A S Slutsky; T E Stewart
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

3.  Diabetes mellitus: a negative predictor for the development of acute respiratory distress syndrome from septic shock.

Authors:  J A Frank; T J Nuckton; M A Matthay
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

Review 4.  Thirty years of clinical trials in acute respiratory distress syndrome.

Authors:  R C McIntyre; E J Pulido; D D Bensard; B D Shames; E Abraham
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

Review 5.  Acute lung injury and acute respiratory distress syndrome. The clinical syndrome.

Authors:  K P Steinberg; L D Hudson
Journal:  Clin Chest Med       Date:  2000-09       Impact factor: 2.878

6.  Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome.

Authors:  M D Zilberberg; S K Epstein
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

7.  Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome.

Authors:  M O Meade; R J Cook; G H Guyatt; R Groll; J R Kachura; M Bedard; D J Cook; A S Slutsky; T E Stewart
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

8.  Interobserver variability in applying a radiographic definition for ARDS.

Authors:  G D Rubenfeld; E Caldwell; J Granton; L D Hudson; M A Matthay
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 9.  Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation.

Authors:  E Abraham; M A Matthay; C A Dinarello; J L Vincent; J Cohen; S M Opal; M Glauser; P Parsons; C J Fisher; J E Repine
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

10.  Diabetic patients have a decreased incidence of acute respiratory distress syndrome.

Authors:  M Moss; D M Guidot; K P Steinberg; G F Duhon; P Treece; R Wolken; L D Hudson; P E Parsons
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

View more
  46 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Current status of severe acute respiratory syndrome in China.

Authors:  Qing-He Nie; Xin-Dong Luo; Jian-Zhong Zhang; Qin Su
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 3.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

4.  Stevioside suppressed inflammatory cytokine secretion by downregulation of NF-κB and MAPK signaling pathways in LPS-stimulated RAW264.7 cells.

Authors:  Li Fengyang; Fu Yunhe; Liu Bo; Liu Zhicheng; Li Depeng; Liang Dejie; Zhang Wen; Cao Yongguo; Zhang Naisheng; Zhang Xichen; Yang Zhengtao
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

5.  Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome.

Authors:  Olivier Lesur; Stephan Langevin; Yves Berthiaume; Martin Légaré; Yoanna Skrobik; Jean-François Bellemare; Bruno Lévy; Yvan Fortier; Francois Lauzier; Gina Bravo; Marc Nickmilder; Eric Rousseau; Alfred Bernard
Journal:  Intensive Care Med       Date:  2006-06-23       Impact factor: 17.440

6.  Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.

Authors:  Koji Kuronuma; Hiroaki Mitsuzawa; Katsuyuki Takeda; Chiaki Nishitani; Edward D Chan; Yoshio Kuroki; Mari Nakamura; Dennis R Voelker
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

7.  ["Malignant" ARDS].

Authors:  S K Metzelder; C Reinke; E M Walthers; P Barth; C Vogelmeier; A Neubauer; R Bals
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

8.  Clinical Aspects of Acute Lung Insufficiency (ALI/TRALI).

Authors:  Matthias Hecker; Hans-Dieter Walmrath; Werner Seeger; Konstantin Mayer
Journal:  Transfus Med Hemother       Date:  2008-03-10       Impact factor: 3.747

9.  Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models.

Authors:  Hailong Huang; Guixue Hu; Chunfeng Wang; Hao Xu; Xiaoqing Chen; Aidong Qian
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

10.  Bergenin Plays an Anti-Inflammatory Role via the Modulation of MAPK and NF-κB Signaling Pathways in a Mouse Model of LPS-Induced Mastitis.

Authors:  Xue-jiao Gao; Meng-yao Guo; Ze-cai Zhang; Tian-cheng Wang; Yong-guo Cao; Nai-sheng Zhang
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.